Astrocytic VEGFA : An essential mediator in blood–brain‐barrier disruption in Parkinson's disease

Cited by (122)

Items 101–122 of 122

  1. The Role of Blood-Retinal Barrier in Retinal Neurodegenerative Diseases
    Lysander Blankenborg, Bela Anand‐Apte, Saptarshi Biswas · 2026 · American Journal Of Pathology
  2. Astrocytes orchestrate neuroprotection and pathogenesis via bidirectional neuronal interactions in Parkinson’s disease
    Yifan Li, Qiang Li, Yemin Wang, Xuejing Wang, Guangfu Di, Meng Niu, Zhiliang Xu, Yanjiao Huang · 2026 · Journal of Physiology and Biochemistry
  3. Isolation of Capillaries from Small Amounts of Mouse Brain Tissue
    Junqiao Mi, Aili Sun, Laura Härtel, Christina Dilling, Patrick Meybohm, Małgorzata Burek · 2024 · Methods in molecular biology
  4. Accumulation of Alpha-Synuclein and Increase in the Inflammatory Response in the substantia nigra, Jejunum, and Colon in a Model of O3 Pollution in Rats
    Marlen Valdés‐Fuentes, Erika Rodrı́guez-Martı́nez, Selva Rivas-Arancibia · 2024 · International Journal of Molecular Sciences
  5. Serum exosome-mediated expression of ITGAX in hippocampus as a novel mechanism of blood-brain barrier dysfunction in epilepsy
    Nian Wei, Jing Wang, Zhenzhen Tai, Changyin Yu, Zucai Xu · 2022 · Research Square
  6. REMOVED: Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson’s disease with emotional stress
    Lianyuan Feng, Aruna Sharma, Zhenguo Wang, Dafin Fior Muresanu, Z. Ryan Tian, José Vicente Lafuente, Anca Dana Buzoianu, Ala Nozari, Cong Li, Ziquiang Zhang et al. · 2023 · International review of neurobiology
  7. Loss of TREM2 function in mice leads to blood-brain barrier impairment, pathological leakage, and cognitive deficits due to microglial CCL2 upregulation
    Yi Tang, Han-Chen Yang, Yunsi Yin, Meng Wang, Bao‐Dong He, Liang Ye, Ruiyang Li, Chao-Ji Yu, Run Di, Qing Xu et al. · 2024 · Research Square
  8. Seasonal and comparative evidence of adaptive gene expression in mammalian brain size plasticity
    William R. Thomas, Troy A. Richter, Erin T O’Neil, Cecilia Baldoni, Angélique Corthals, Dominik von Elverfeldt, John D. Nieland, Dina K. N. Dechmann, Richard G Hunter, Liliana M. Dávalos · 2025 · eLife
  9. Microphysiological engineering of the capillary interface of substantia nigra dopaminergic neurons to study vascular alterations in Parkinson’s Disease
    Anika Alim, Yoongyeong Baek, Myungwoon Lee, Jungwook Paek · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Parkinson's Disease and Cancer: Mechanistic Insights and Therapeutic Opportunities From Cancer Neuroscience
    Tianli Pan, Lin Yuan, Ruoyang Zhao, Liting Lu, Yinghao Zhi, Yuying Li, Min Wu, Yongye Huang · 2025 · MedComm – Oncology
  11. Additional file 1 of Transcriptome sequencing and network pharmacology-based approach to reveal the effect and mechanism of Ji Chuan Jian against Parkinson’s disease
    Wu, Yao, Bai, Yu, Lu, Yan, Zhennian Zhang, Zhao, Yang, Huang, Sirui, Tang, Lili, Yan Liang, Hu, Yue, Xu, Chengcheng · 2024 · Figshare
  12. Additional file 1 of α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis
    Wang, Pan, Lan, Guoyu, Xu, Bin, Yu, Zhenwei, Chen Tian, Lei, Xia, Wassilios G. Meissner, Feng, Tao, Ying Yang, Zhang, Jing · 2024 · Figshare
  13. Genome‐Wide Association Studies Data and Transcriptomics Data Link Herpes Simplex Virus 1 Infection and Parkinson’s Disease
    Changhao Lu, X CAI, Elena Rita Simula, Tommaso Ercoli, Paolo Solla, Leonardo Antonio Sechi · 2025 · Parkinson s Disease
  14. Natural Killer Subset Changes and Vascular Endothelial Growth Factor‐A Plasma Profile in Progressive Supranuclear Palsy: The NKscape Study
    Marina Picillo, Cristina Basile, Francesco Montella, Valentina Lopardo, Mariangela Orlando, Roberta Tarallo, Domenico Palumbo, Viola Melone, Maria Francesca Tepedino, Paolo Barone et al. · 2026 · Movement Disorders
  15. The role and mechanisms of AMPK in neurovascular unit injury in Parkinson’s disease
    Bingqian Liu, Nan Li, Gaofang Fan, Zhifu Guo, Ke Wang, Lingyao Kong · 2026 · Frontiers in Aging Neuroscience
  16. Battle of the wall for aromatic “orifice-opening” agents: defending and breaching the blood-brain barrier
    Xiaoman Yang, Jing Zhang, Hao Yu, Yulei Zhao, Guanqun Hou, Shijun Wang, Bingbing Han · 2026 · Chinese Journal of Natural Medicines
  17. Retinal Vascularity Index in Parkinson’s Disease
    John Hsu, Rachel D’Cunha, Alex Choi, Michael Zhu, Alice Haystead, Sandra S. Stinnett, Atharva Hudlikar, Rachel Song, Hans Ng, Rupesh V. Agrawal et al. · 2026 · Ophthalmology Science
  18. Use of receptor and nonreceptor tyrosine kinase inhibitors and Parkinson disease risk
    Giovanni R. Malaty, Jordan A. Killion, Sai Anmisha Doddamreddy, Osvaldo Laurido-Soto, Brad Alan Racette · 2026 · Neurotherapeutics
  19. HSPA8 orchestrates SNARE complex assembly to drive extracellular vesicle-mediated spread of p-tau217 in Alzheimer's disease
    Bin Xu, Zhen Guo, Jun Chen, Yazhou Xie, Pan Wang, Xiong Xiao, Jiayi Yu, Zhi Xu, Yuan Fu, Zhuoqing Lan et al. · 2026 · Translational Neurodegeneration
  20. Astrocyte lipid metabolism: From physiological homeostasis to reactive phenotype plasticity in neurodegeneration
    Hao Chen, Xi-Ning Cui, Mengyan Deng · 2026 · Neurochemistry International
  21. Astrocytic PDE7B Drives Blood–Brain Barrier Breakdown via Extracellular Vesicles in Demyelinating Disease
    段静, Yumeng La, Jun Chen, Zhi Xu, Zhen Guo, Chen Tian, Bin Xu, Jing Zhang · 2026 · Glia
  22. Convergent Astrocytic Failure in Parkinson’s Disease: A System-Level Model of Pathogenesis and Treatment
    Ahmed M Abdelaziz, Mohamed N Fawzy, Mustafa M Shokr · 2026 · Molecular Neurobiology